nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP2D6—Parkinson's disease	0.828	1	CbGaD
Hydrocodone—OPRM1—telencephalic ventricle—Parkinson's disease	0.00883	0.159	CbGeAlD
Hydrocodone—OPRM1—nerve—Parkinson's disease	0.00557	0.1	CbGeAlD
Hydrocodone—OPRD1—forebrain—Parkinson's disease	0.00338	0.0608	CbGeAlD
Hydrocodone—OPRK1—forebrain—Parkinson's disease	0.00324	0.0583	CbGeAlD
Hydrocodone—OPRM1—brainstem—Parkinson's disease	0.00239	0.0429	CbGeAlD
Hydrocodone—OPRM1—forebrain—Parkinson's disease	0.00231	0.0414	CbGeAlD
Hydrocodone—OPRD1—head—Parkinson's disease	0.00194	0.0348	CbGeAlD
Hydrocodone—OPRK1—head—Parkinson's disease	0.00186	0.0334	CbGeAlD
Hydrocodone—OPRD1—nervous system—Parkinson's disease	0.00184	0.033	CbGeAlD
Hydrocodone—OPRD1—central nervous system—Parkinson's disease	0.00177	0.0318	CbGeAlD
Hydrocodone—OPRK1—nervous system—Parkinson's disease	0.00176	0.0316	CbGeAlD
Hydrocodone—OPRK1—central nervous system—Parkinson's disease	0.00169	0.0304	CbGeAlD
Hydrocodone—CYP2D6—hindbrain—Parkinson's disease	0.00167	0.03	CbGeAlD
Hydrocodone—OPRK1—cerebellum—Parkinson's disease	0.00166	0.0298	CbGeAlD
Hydrocodone—OPRM1—midbrain—Parkinson's disease	0.00152	0.0274	CbGeAlD
Hydrocodone—OPRM1—spinal cord—Parkinson's disease	0.00149	0.0267	CbGeAlD
Hydrocodone—Galantamine—CHRNA4—Parkinson's disease	0.00145	0.132	CrCbGaD
Hydrocodone—OPRD1—brain—Parkinson's disease	0.0014	0.0252	CbGeAlD
Hydrocodone—OPRK1—brain—Parkinson's disease	0.00135	0.0242	CbGeAlD
Hydrocodone—OPRM1—head—Parkinson's disease	0.00132	0.0237	CbGeAlD
Hydrocodone—OPRM1—nervous system—Parkinson's disease	0.00125	0.0225	CbGeAlD
Hydrocodone—OPRM1—central nervous system—Parkinson's disease	0.00121	0.0217	CbGeAlD
Hydrocodone—Dextromethorphan—CHRNA4—Parkinson's disease	0.00109	0.0989	CrCbGaD
Hydrocodone—Methylnaltrexone—CYP2D6—Parkinson's disease	0.001	0.0913	CrCbGaD
Hydrocodone—CYP2D6—brainstem—Parkinson's disease	0.000958	0.0172	CbGeAlD
Hydrocodone—OPRM1—brain—Parkinson's disease	0.000957	0.0172	CbGeAlD
Hydrocodone—CYP2D6—forebrain—Parkinson's disease	0.000924	0.0166	CbGeAlD
Hydrocodone—Dihydrocodeine—CYP2D6—Parkinson's disease	0.000853	0.0777	CrCbGaD
Hydrocodone—Oxymorphone—CYP2D6—Parkinson's disease	0.000748	0.0681	CrCbGaD
Hydrocodone—Ethylmorphine—CYP2D6—Parkinson's disease	0.000715	0.0651	CrCbGaD
Hydrocodone—Oxycodone—CYP2D6—Parkinson's disease	0.000596	0.0543	CrCbGaD
Hydrocodone—Codeine—CYP2D6—Parkinson's disease	0.000569	0.0518	CrCbGaD
Hydrocodone—Hydromorphone—CYP2D6—Parkinson's disease	0.000542	0.0493	CrCbGaD
Hydrocodone—Naltrexone—ABCB1—Parkinson's disease	0.000534	0.0486	CrCbGaD
Hydrocodone—CYP2D6—head—Parkinson's disease	0.000529	0.00951	CbGeAlD
Hydrocodone—Dextromethorphan—CYP2E1—Parkinson's disease	0.000527	0.048	CrCbGaD
Hydrocodone—Galantamine—CYP2D6—Parkinson's disease	0.000517	0.047	CrCbGaD
Hydrocodone—CYP3A4—nervous system—Parkinson's disease	0.00051	0.00917	CbGeAlD
Hydrocodone—CYP2D6—nervous system—Parkinson's disease	0.000502	0.00902	CbGeAlD
Hydrocodone—CYP3A4—central nervous system—Parkinson's disease	0.000491	0.00882	CbGeAlD
Hydrocodone—CYP2D6—central nervous system—Parkinson's disease	0.000483	0.00868	CbGeAlD
Hydrocodone—CYP2D6—cerebellum—Parkinson's disease	0.000472	0.00849	CbGeAlD
Hydrocodone—Morphine—CYP2D6—Parkinson's disease	0.000461	0.0419	CrCbGaD
Hydrocodone—Naloxone—ABCB1—Parkinson's disease	0.00039	0.0355	CrCbGaD
Hydrocodone—Dextromethorphan—CYP2D6—Parkinson's disease	0.000387	0.0352	CrCbGaD
Hydrocodone—CYP2D6—brain—Parkinson's disease	0.000384	0.00689	CbGeAlD
Hydrocodone—Morphine—ABCB1—Parkinson's disease	0.000329	0.0299	CrCbGaD
Hydrocodone—Dextromethorphan—ABCB1—Parkinson's disease	0.000276	0.0251	CrCbGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00015	0.00142	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000149	0.00142	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.000147	0.00139	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.000144	0.00136	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.000144	0.00136	CbGpPWpGaD
Hydrocodone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000142	0.00135	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000141	0.00133	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00014	0.00133	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—GRM5—Parkinson's disease	0.00014	0.00133	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PENK—Parkinson's disease	0.000139	0.00132	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000139	0.00132	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000138	0.00131	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RIT2—Parkinson's disease	0.000137	0.0013	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—EDN1—Parkinson's disease	0.000136	0.00129	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000136	0.00129	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000136	0.00129	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000135	0.00128	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000132	0.00125	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000131	0.00124	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GRK5—Parkinson's disease	0.00013	0.00124	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00013	0.00123	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000129	0.00123	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000128	0.00121	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.000127	0.00121	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GPR37—Parkinson's disease	0.000127	0.00121	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.000127	0.00121	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000125	0.00119	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—IL6—Parkinson's disease	0.000124	0.00118	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000121	0.00115	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RIT2—Parkinson's disease	0.00012	0.00114	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000119	0.00113	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000119	0.00113	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.000118	0.00112	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000118	0.00112	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GRM4—Parkinson's disease	0.000117	0.00111	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000116	0.00111	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000116	0.0011	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000116	0.0011	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—TAC1—Parkinson's disease	0.000116	0.0011	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000116	0.0011	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.000115	0.00109	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000115	0.00109	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000114	0.00108	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GRK5—Parkinson's disease	0.000114	0.00108	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—DRD1—Parkinson's disease	0.000114	0.00108	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000114	0.00108	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000113	0.00107	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000112	0.00106	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PENK—Parkinson's disease	0.000111	0.00105	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAG—Parkinson's disease	0.000111	0.00105	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000111	0.00105	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—DRD3—Parkinson's disease	0.00011	0.00104	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00011	0.00104	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HTR7—Parkinson's disease	0.00011	0.00104	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—DRD2—Parkinson's disease	0.00011	0.00104	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000107	0.00101	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000106	0.00101	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000105	0.000997	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000103	0.000978	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000103	0.000974	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GRM4—Parkinson's disease	0.000102	0.000972	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RIT2—Parkinson's disease	0.000102	0.000966	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—TAC1—Parkinson's disease	0.000102	0.000963	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PDYN—Parkinson's disease	0.000101	0.000961	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000101	0.000954	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.0001	0.000953	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.0001	0.000953	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—DRD1—Parkinson's disease	9.96e-05	0.000945	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HTR7—Parkinson's disease	9.95e-05	0.000944	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—DRD2—Parkinson's disease	9.95e-05	0.000944	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—ADRBK1—Parkinson's disease	9.92e-05	0.000941	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	9.91e-05	0.00094	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PENK—Parkinson's disease	9.71e-05	0.000921	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAG—Parkinson's disease	9.71e-05	0.000921	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GRK5—Parkinson's disease	9.65e-05	0.000916	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—DRD3—Parkinson's disease	9.64e-05	0.000915	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HTR7—Parkinson's disease	9.6e-05	0.000911	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—DRD2—Parkinson's disease	9.6e-05	0.000911	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	9.6e-05	0.00091	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GFAP—Parkinson's disease	9.52e-05	0.000903	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—TAC1—Parkinson's disease	9.45e-05	0.000897	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GRM5—Parkinson's disease	9.41e-05	0.000893	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—DRD1—Parkinson's disease	9.27e-05	0.000879	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	9.19e-05	0.000872	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.06e-05	0.00086	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—ADRBK1—Parkinson's disease	9.01e-05	0.000854	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—DRD3—Parkinson's disease	8.98e-05	0.000851	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PDYN—Parkinson's disease	8.88e-05	0.000842	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—EDN1—Parkinson's disease	8.77e-05	0.000832	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HTR7—Parkinson's disease	8.72e-05	0.000827	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—DRD2—Parkinson's disease	8.72e-05	0.000827	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HTR1A—Parkinson's disease	8.71e-05	0.000827	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GRM4—Parkinson's disease	8.66e-05	0.000821	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—TAC1—Parkinson's disease	8.58e-05	0.000814	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—DRD1—Parkinson's disease	8.42e-05	0.000798	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.38e-05	0.000795	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GFAP—Parkinson's disease	8.35e-05	0.000792	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GRM5—Parkinson's disease	8.26e-05	0.000783	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FGF20—Parkinson's disease	8.26e-05	0.000783	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PENK—Parkinson's disease	8.21e-05	0.000778	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAG—Parkinson's disease	8.21e-05	0.000778	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—DRD3—Parkinson's disease	8.15e-05	0.000773	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—DRD2—Parkinson's disease	8.12e-05	0.00077	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HTR7—Parkinson's disease	8.12e-05	0.00077	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ADORA2A—Parkinson's disease	8.01e-05	0.000759	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—EDN1—Parkinson's disease	7.96e-05	0.000755	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—EDN1—Parkinson's disease	7.69e-05	0.000729	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HTR2A—Parkinson's disease	7.67e-05	0.000728	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—COMT—Parkinson's disease	7.62e-05	0.000722	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	7.61e-05	0.000722	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	7.58e-05	0.000719	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	7.56e-05	0.000717	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MCCC1—Parkinson's disease	7.55e-05	0.000717	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ND3—Parkinson's disease	7.55e-05	0.000717	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	7.51e-05	0.000713	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PDYN—Parkinson's disease	7.51e-05	0.000712	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	7.48e-05	0.000709	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—INSR—Parkinson's disease	7.39e-05	0.000701	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HTR7—Parkinson's disease	7.37e-05	0.000699	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—DRD2—Parkinson's disease	7.37e-05	0.000699	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FGF20—Parkinson's disease	7.24e-05	0.000687	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TALDO1—Parkinson's disease	7.1e-05	0.000674	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—OMD—Parkinson's disease	7.1e-05	0.000674	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GFAP—Parkinson's disease	7.06e-05	0.000669	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADORA2A—Parkinson's disease	7.02e-05	0.000666	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—EDN1—Parkinson's disease	6.98e-05	0.000662	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FGB—Parkinson's disease	6.98e-05	0.000662	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GRM5—Parkinson's disease	6.98e-05	0.000662	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HTR2A—Parkinson's disease	6.97e-05	0.000661	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	6.97e-05	0.000661	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HTR1A—Parkinson's disease	6.95e-05	0.000659	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	6.87e-05	0.000652	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TAC1—Parkinson's disease	6.84e-05	0.000649	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	6.73e-05	0.000639	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HTR2A—Parkinson's disease	6.73e-05	0.000638	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—DRD1—Parkinson's disease	6.71e-05	0.000636	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—EDN1—Parkinson's disease	6.5e-05	0.000617	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—DRD3—Parkinson's disease	6.5e-05	0.000616	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—INSR—Parkinson's disease	6.48e-05	0.000615	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.42e-05	0.000609	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FGB—Parkinson's disease	6.12e-05	0.000581	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGF20—Parkinson's disease	6.12e-05	0.00058	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HTR2A—Parkinson's disease	6.11e-05	0.00058	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HTR1A—Parkinson's disease	6.09e-05	0.000578	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ADRBK1—Parkinson's disease	6.07e-05	0.000576	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TAC1—Parkinson's disease	6e-05	0.000569	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADORA2A—Parkinson's disease	5.93e-05	0.000563	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—EDN1—Parkinson's disease	5.9e-05	0.00056	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—DRD1—Parkinson's disease	5.88e-05	0.000558	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—DRD2—Parkinson's disease	5.88e-05	0.000557	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HTR7—Parkinson's disease	5.88e-05	0.000557	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—FBP1—Parkinson's disease	5.72e-05	0.000543	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GBA—Parkinson's disease	5.72e-05	0.000543	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—DBH—Parkinson's disease	5.72e-05	0.000543	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—DRD3—Parkinson's disease	5.7e-05	0.00054	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	5.69e-05	0.000539	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—INSR—Parkinson's disease	5.48e-05	0.000519	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADRBK1—Parkinson's disease	5.32e-05	0.000505	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGB—Parkinson's disease	5.17e-05	0.000491	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HTR2A—Parkinson's disease	5.16e-05	0.00049	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—DRD2—Parkinson's disease	5.15e-05	0.000489	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HTR7—Parkinson's disease	5.15e-05	0.000489	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR1A—Parkinson's disease	5.15e-05	0.000488	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TAC1—Parkinson's disease	5.07e-05	0.000481	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—DRD1—Parkinson's disease	4.97e-05	0.000472	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ND3—Parkinson's disease	4.94e-05	0.000468	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.94e-05	0.000468	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IGF2—Parkinson's disease	4.92e-05	0.000467	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—DRD3—Parkinson's disease	4.81e-05	0.000457	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IGF1R—Parkinson's disease	4.76e-05	0.000452	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EDN1—Parkinson's disease	4.7e-05	0.000446	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—OMD—Parkinson's disease	4.64e-05	0.00044	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.64e-05	0.00044	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADRBK1—Parkinson's disease	4.5e-05	0.000427	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.4e-05	0.000418	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—DRD2—Parkinson's disease	4.35e-05	0.000413	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR7—Parkinson's disease	4.35e-05	0.000413	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NGF—Parkinson's disease	4.32e-05	0.00041	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IGF2—Parkinson's disease	4.32e-05	0.00041	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—DDC—Parkinson's disease	4.2e-05	0.000399	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.2e-05	0.000398	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IGF1R—Parkinson's disease	4.17e-05	0.000396	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EDN1—Parkinson's disease	4.12e-05	0.000391	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HTR2A—Parkinson's disease	4.12e-05	0.00039	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.97e-05	0.000376	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—APOE—Parkinson's disease	3.83e-05	0.000363	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NGF—Parkinson's disease	3.79e-05	0.00036	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.74e-05	0.000355	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—DBH—Parkinson's disease	3.74e-05	0.000355	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GBA—Parkinson's disease	3.74e-05	0.000355	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF2—Parkinson's disease	3.65e-05	0.000346	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HTR2A—Parkinson's disease	3.61e-05	0.000342	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.57e-05	0.000339	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.54e-05	0.000336	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	3.53e-05	0.000335	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	3.49e-05	0.000331	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APOE—Parkinson's disease	3.35e-05	0.000318	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—INS—Parkinson's disease	3.27e-05	0.00031	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NGF—Parkinson's disease	3.2e-05	0.000304	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	3.05e-05	0.000289	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—INS—Parkinson's disease	2.87e-05	0.000272	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOE—Parkinson's disease	2.84e-05	0.000269	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—DDC—Parkinson's disease	2.75e-05	0.000261	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.59e-05	0.000246	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.58e-05	0.000245	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CASP3—Parkinson's disease	2.43e-05	0.000231	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—INS—Parkinson's disease	2.42e-05	0.00023	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—Parkinson's disease	2.42e-05	0.000229	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.4e-05	0.000228	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.38e-05	0.000226	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TH—Parkinson's disease	2.34e-05	0.000222	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.34e-05	0.000222	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.31e-05	0.000219	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.25e-05	0.000213	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK8—Parkinson's disease	2.24e-05	0.000212	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CASP3—Parkinson's disease	2.13e-05	0.000202	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—Parkinson's disease	2.12e-05	0.000201	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—COMT—Parkinson's disease	1.99e-05	0.000189	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.98e-05	0.000188	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.98e-05	0.000188	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK8—Parkinson's disease	1.96e-05	0.000186	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.96e-05	0.000185	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.88e-05	0.000178	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.82e-05	0.000173	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	1.8e-05	0.000171	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	1.79e-05	0.00017	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.74e-05	0.000166	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.72e-05	0.000163	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.69e-05	0.00016	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.66e-05	0.000157	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.61e-05	0.000153	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.57e-05	0.000149	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.55e-05	0.000147	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TH—Parkinson's disease	1.53e-05	0.000145	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOE—Parkinson's disease	1.5e-05	0.000142	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.47e-05	0.00014	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—Parkinson's disease	1.43e-05	0.000135	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—COMT—Parkinson's disease	1.3e-05	0.000124	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.3e-05	0.000123	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.29e-05	0.000123	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—INS—Parkinson's disease	1.28e-05	0.000121	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.28e-05	0.000121	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—Parkinson's disease	1.25e-05	0.000119	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.23e-05	0.000116	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.19e-05	0.000113	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.14e-05	0.000108	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—Parkinson's disease	1.06e-05	0.0001	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.05e-05	9.99e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOE—Parkinson's disease	9.8e-06	9.3e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—INS—Parkinson's disease	8.37e-06	7.94e-05	CbGpPWpGaD
